The 51st Annual Psychopharmacology Conference, hosted by the Massachusetts General Hospital Psychiatry Academy, takes place from October 21 to October 24, 2027, at the Westin Copley Place in Boston, Massachusetts, with a full virtual attendance option available. Advancing psychiatric care for more than five decades, this annual conference connects clinicians with emerging evidence, therapeutic advances in psychopharmacology, and practical insights designed to inform treatment decisions and elevate patient care across diverse psychiatric settings.
The educational program is structured to maintain clinical depth, scientific rigor, and direct practical application. Key focus areas include depression, bipolar disorder, anxiety, psychosis, obsessive-compulsive disorder (OCD), attention-deficit/hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), substance use disorders, as well as integrative approaches and pharmacologic innovations. Sessions assist attendees in keeping pace with emerging psychiatric research, critically evaluating evolving standards of care, and implementing evidence-based prescribing strategies for complex clinical presentations. In addition to didactic lectures, the conference features Curbside Consultations, offering informal, scheduled one-on-one meetings with faculty across various psychiatric subspecialties to discuss nuanced clinical questions and de-identified challenging cases. Thursday ticketed sessions and evening seminars are held on-site for in-person attendees.
Targeted toward psychiatrists, psychologists, general and family practice physicians, psychiatric nurses, physician assistants, nurse practitioners, and social workers, the activity offers up to 32.00 Participation credits. Participation Certificates specify the activity details and number of AMA PRA Category 1 Credit™ associated with completion.
Registration tiers are available for both in-person and virtual formats. For MDs and doctoral-level professionals, pricing is $950.00 for early bird registration (on or before August 15, 2027) and $1085.00 for regular registration (after August 15, 2027). For other professionals or trainees, early bird registration is $750.00 and regular registration is $850.00. Attendees receive complimentary access to an electronic syllabus in digital PDF format for 30 days after the event, or may purchase an optional printed syllabus book onsite for $95.00.
Fees (as published by the organiser): MDs/Doctoral-Level Professionals: Early Bird Registration (on or before August 15, 2027): $950.00, Regular Registration (after August 15, 2027): $1085.00. Other Professionals or Trainees: Early Bird Registration (on or before August 15, 2027): $750.00, Regular Registration (after August 15, 2027): $850.00. Printed Syllabus: $95.00.
Credits: Available Credits: 32.00 Participation. This course allows other providers to claim a Participation Certificate upon successful completion of this course. Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity.
Faculty / directors: Maurizio Fava, MD, Chair, Mass General Brigham Academic Medical Centers (AMC) Department of Psychiatry; Co-Chair, Mass General Brigham Research Oversight Committee (ROC); Executive Director, CTNI; Slater Family Professor of Psychiatry, Mass General Brigham and Harvard Medical School; Jerrold F. Rosenbaum, MD, Psychiatrist-in-Chief Emeritus; Director, Center for the Neuroscience of Psychedelics; Stanley Cobb Professor of Psychiatry, Massachusetts General Hospital and Harvard Medical School